LYRICA (pregabalin) by Viatris is (pregabalin) binds with high affinity to the alpha 2 -delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. First approved in 2004.
Drug data last refreshed 2m ago · AI intelligence enriched 5d ago
LYRICA (pregabalin) is an oral small-molecule anticonvulsant and analgesic approved in 2004 that binds to alpha-2-delta subunits of voltage-gated calcium channels in the central nervous system. It is indicated for neuropathic pain, fibromyalgia, and seizure disorders by reducing pro-nociceptive neurotransmitter release and modulating descending pain pathways. The mechanism involves calcium channel disruption and interactions with brainstem noradrenergic and serotonergic systems rather than direct GABA receptor binding.
Product approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential team consolidation and focus shift toward generic transition management.
(pregabalin) binds with high affinity to the alpha 2 -delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of pregabalin has not been fully elucidated, results with genetically modified mice and with compounds…
Worked on LYRICA at Viatris? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants
Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia
Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair
Working on LYRICA at the LOE stage means supporting a defensive market position and managing generic transition rather than driving growth innovation. Career value derives from real-world evidence generation, payer negotiations, and operational efficiency in a declining revenue environment.